Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

June 5, 2023

PHILADELPHIA, PA – June 5, 2023 – Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several investor conferences in June 2023. These investor conferences include: Jefferies Global Healthcare Conference Steven...

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

May 30, 2023

PHILADELPHIA, PA – May 30, 2023 – Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several healthcare industry conferences in June 2023. These conferences include: 2023 American Society of...

Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

May 8, 2023

PHILADELPHIA, PA – May 8, 2023 – Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Monday, May 15 at...